Innovations in Cancer Vaccines
The upcoming Immunity for health Symposium 2025 is a distinguished gathering focused on pioneering research and groundbreaking developments in Cancer Vaccines for both human and veterinary medicine.
This scientific event will take place on May 22, 2025, in Antwerp, providing a unique platform for experts from academia and industry to exchange knowledge and discuss the most recent progress in the field.
This symposium will highlight the latest innovations, including dendritic cell-based vaccines, novel antigen discovery, mRNA vaccine platforms, therapeutic vaccine applications, and advancements in manufacturing techniques. Participants will have the opportunity to engage with leading scientists, gain insights into cutting-edge research, and foster collaborations that drive the future of cancer immunotherapy.
>>> MORE INFO & REGISTRATION <<<
PROGRAMME
13:30 Registration and welcome coffee
14:00 Welcome by Immunity for health
14:05 Cancer Vaccines: from concept to reality – Prof. Jo Van Ginderachter, VUB-VIB
14:35 SHORT ACADEMIA TALKS
- Single-Cell Analysis During Checkpoint Immunotherapy Reveals the Tumor Antigen Landscape, Advancing Cancer Vaccine Development - Prof. Diether Lambrechts, KU Leuven
- GMP Manufacturing of small batches of RNA-based Vaccines in an academic setting - Tim Desmet, Ghent University
- From Vein to Vaccine: dendritic cell vaccination for pediatric patients with high-grade glioma and diffuse intrinsic pontine glioma - Dr. Toon Van Genechten, University Hospital Antwerp
- Q&A
15:30 Coffee break
16:00 SHORT COMPANY TALKS
- An advanced UGent/UZGent platform for Dendritic Cell-based therapy in immune checkpoint-resistant cancers - Prof. Dr. Karim Vermaelen, Sparxells/Ghent University
- Identifying a novel class of shared tumor antigens through an advanced neoantigen discovery pipeline - Gitta Boons, MyNEO Therapeutics
- AVX70561, an innovative immunotherapy for treatment of persistent HPV-infection - Lien Van Eyck, Astrivax Therapeutics
- A novel, non-invasive approach to treat canine cancer - Annelies Bogaerts, Benno Therapeutics
- Q&A
17:00 Networking reception
CALL FOR SPONSORS
To make this event a success, we are seeking sponsors who share our commitment to advancing vaccine development. By becoming an Event Sponsor, your organization will:
- Gain valuable visibility within the immuno-oncology community
- Connect with key decision-makers and research pioneers
- Demonstrate your commitment to advancing cancer treatment solutions
- Support critical knowledge exchange in vaccine innovation
Immunity for health members receive a 15% discount on our sponsorship package.
ℹ️ Check out our sponsorship brochure.
Our members & strategic partners
Organizations with expertise in immunology, oncology, vaccinology and infectious diseases, are invited to join Immunity for Health. Together, we build a strong network, fostering innovation in diagnostics, medical devices, immunotherapeutics, and vaccines for humans and animals and across the entire value chain—from R&D to manufacturing, supply, marketing, and beyond. Join us to make impact!
